Panpan Ji et al. used a type of intelligent exosomes in which the exosome surface was modified with CD62L (L-selectin as a marker for tumor-draining lymph nodes (TDLNs)) and OX40L (a gene for activating T-cells and inhibiting regulatory T-cells). Here, SELL is linked to neoplasm.